A Phase 1 Pharmacokinetics and Pharmacodynamics of Ketamine Transdermal Drug Delivery System in Subjects With Sub-Optimally Responsive Major Depressive Disorders
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 26 Apr 2019
Price : $35 *
At a glance
- Drugs Ketamine (Primary)
- Indications Major depressive disorder
- Focus First in man; Pharmacokinetics
- Sponsors Shenox Pharmaceuticals
- 24 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 28 Jan 2019 Status changed from not yet recruiting to recruiting.
- 02 Nov 2018 New trial record